Print page | Close Window

Aptus Endosystems Announces New Product Names

Sunnyvale, Calif., October 31, 2011 —Aptus Endosystems, Inc., a medical device company developing advanced technology for treating abdominal aortic aneurysms (AAA), unveiled today the new names for its innovative systems: Fortevo and HeliFX.

The Fortevo^™ AAA Endograft System (formerly named the Aptus Endograft) and the HeliFX^™ Aortic Securement System (formerly named the Aptus EndoStapling System) received name changes to better reflect the scope of the products, and to appeal to a broader audience of physicians as well as patients.

“With the recent CE Mark approval and the anticipated FDA clearance of HeliFX, it is the right time to change,” explained Jeff Elkins, CEO of Aptus Endosystems. “The former names were descriptive and generic. We have truly innovative medical devices and we want to get that point across with well thought out product names”.

The name “Fortevo” not only evokes a more positive and strong image, but it also describes a major benefit of the endograft: long term durability (or fortitude) which is an evolution in endovascular aneurysm repair. In addition, the name “HeliFX” projects a similar image of strength and more aptly describes the helical fixation system consisting of EndoAnchor^™ implants and catheter based components with motorized controls for delivery and implantation.

About Aptus Endosystems, Inc.

Headquartered in Sunnyvale, California, Aptus Endosystems is a privately held medical device company focused on developing advanced technology for endovascular aneurysm repair (EVAR). An estimated 1.5 million Americans have an abdominal aortic aneurysm (AAA), which can be life-threatening if left untreated, and approximately 200,000 people are newly diagnosed each year. Aptus Endosystems has developed a unique endograft and innovative helical anchor technology that allows physicians to perform minimally invasive EVAR while still providing the control and potential long term durability of an open surgical repair. The Fortevo^™ AAA Endograft System and the HeliFX^™ Aortic Securement System bear the CE Mark for distribution in the European Union. These products are Investigational Use Only in the United States. For more information, please visit www.aptusendosystems.com.

# # #

Media Contact

Top | Close Window